Trend of ST-segment elevation myocardial infarction in Tianjin from 2001 to 2011

蒋子涵,李静,张海波,白雪珂,陈红
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2016.24.023
2016-01-01
Abstract:Objective To assess the trends in clinical characteristics, treatments, and outcomes for hospitalized patients with ST-segment elevation myocardial infarction (STEMI) in Tianjin from 2001 to 2011. Methods We selected patients admitted to two hospitals for STEMI in 3 years (2001, 2006 and 2011) to represent the overall situation. Patient information was obtained from medical record via central abstraction. Then we compared patients' clinical characteristics, diagnosis and treatment, and clinical outcomes among these 3 years. Results In total, 526 STEMI patients from two hospitals were included in this analysis. Between 2001 and 2011, the median age and the percentage of female of STEMI patients didn’t change. The proportion of patients who with more than 2 cardiovascular risk factors increased from 8.3% to 31.4% (Ptrend<0.000 1). Among patients without documented contraindications, use of primary percutaneous coronary intervention (PCI) increased from 10.7% in 2001 to 78.6% in 2011 (Ptrend=0.004 9), and the proportion of patients who received reperfusion increased from 78.6% to 82.9% (Ptrend=0.045 9). Significant increases were noted in use of medicines Clopidogrel and statins within 24 h. The mortality rates within 7 days following admission declined from 10.1% to 1.9% (Ptrend=0.004 3), and the proportions&nbsp;of death or treatment declined from 10.1% to 2.2% (Ptrend=0.002 1). Conclusions During the past decade in Tianjin, there has been a rapid increase in application of new technology and drugs for the treatment of patients with STEMI. And the outcomes of patients have been improved. However, important gaps persist between clinical practice and guideline recommendations.
What problem does this paper attempt to address?